标题 |
An open-label, single-arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR-positive, HER2-negative advanced breast cancer patients: BRIGHT-1 trial. Cancer Commun (Lond)
bireociclib作为单药治疗重度预处理的HR阳性、HER2阴性晚期乳腺癌患者的开放标签、单臂、多中心、II期试验:BRIGHT-1试验。常见癌症(伦敦)
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | Wang J, Zhang Q, Sun T, et al. An open-label, single-arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR-positive, HER2-negative advanced breast cancer patients: BRIGHT-1 trial. Cancer Commun (Lond). Published online February 27, 2025. doi:10.1002/cac2.70009 |
求助人 | |
下载 |